| UniProt ID | TBC24_HUMAN | |
|---|---|---|
| UniProt AC | Q9ULP9 | |
| Protein Name | TBC1 domain family member 24 | |
| Gene Name | TBC1D24 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 559 | |
| Subcellular Localization | Cytoplasm . Partially expressed at the plasma membrane. | |
| Protein Description | May act as a GTPase-activating protein for Rab family protein(s). Involved in neuronal projections development, probably through a negative modulation of ARF6 function.. | |
| Protein Sequence | MDSPGYNCFVDKDKMDAAIQDLGPKELSCTELQELKQLARQGYWAQSHALRGKVYQRLIRDIPCRTVTPDASVYSDIVGKIVGKHSSSCLPLPEFVDNTQVPSYCLNARGEGAVRKILLCLANQFPDISFCPALPAVVALLLHYSIDEAECFEKACRILACNDPGRRLIDQSFLAFESSCMTFGDLVNKYCQAAHKLMVAVSEDVLQVYADWQRWLFGELPLCYFARVFDVFLVEGYKVLYRVALAILKFFHKVRAGQPLESDSVKQDIRTFVRDIAKTVSPEKLLEKAFAIRLFSRKEIQLLQMANEKALKQKGITVKQKSVSLSKRQFVHLAVHAENFRSEIVSVREMRDIWSWVPERFALCQPLLLFSSLQHGYSLARFYFQCEGHEPTLLLIKTTQKEVCGAYLSTDWSERNKFGGKLGFFGTGECFVFRLQPEVQRYEWVVIKHPELTKPPPLMAAEPTAPLSHSASSDPADRLSPFLAARHFNLPSKTESMFMAGGSDCLIVGGGGGQALYIDGDLNRGRTSHCDTFNNQPLCSENFLIAAVEAWGFQDPDTQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MDSPGYNCFV -----CCCCCCCCEE | 20.94 | 25159151 | |
| 12 | Acetylation | GYNCFVDKDKMDAAI CCCCEECHHHHHHHH | 54.68 | 27452117 | |
| 28 | Phosphorylation | DLGPKELSCTELQEL HHCCCCCCCHHHHHH | 21.78 | 26657352 | |
| 30 | Phosphorylation | GPKELSCTELQELKQ CCCCCCCHHHHHHHH | 36.03 | 27251275 | |
| 36 | Ubiquitination | CTELQELKQLARQGY CHHHHHHHHHHHCCH | 42.38 | 29967540 | |
| 80 (in isoform 2) | Ubiquitination | - | 24.27 | 21890473 | |
| 80 (in isoform 1) | Ubiquitination | - | 24.27 | 21890473 | |
| 80 | Ubiquitination | VYSDIVGKIVGKHSS HHHHHHHHHHCCCCC | 24.27 | 21890473 | |
| 80 | Ubiquitination | VYSDIVGKIVGKHSS HHHHHHHHHHCCCCC | 24.27 | 21906983 | |
| 84 | Ubiquitination | IVGKIVGKHSSSCLP HHHHHHCCCCCCCCC | 29.44 | 23503661 | |
| 253 | Ubiquitination | AILKFFHKVRAGQPL HHHHHHHHHHCCCCC | 28.41 | 32142685 | |
| 266 (in isoform 1) | Ubiquitination | - | 46.32 | 21890473 | |
| 266 (in isoform 2) | Ubiquitination | - | 46.32 | 21890473 | |
| 266 | Ubiquitination | PLESDSVKQDIRTFV CCCCCCHHHHHHHHH | 46.32 | 29967540 | |
| 278 | Ubiquitination | TFVRDIAKTVSPEKL HHHHHHHHHCCHHHH | 50.20 | 27667366 | |
| 284 | Acetylation | AKTVSPEKLLEKAFA HHHCCHHHHHHHHHH | 62.85 | 23236377 | |
| 284 | Malonylation | AKTVSPEKLLEKAFA HHHCCHHHHHHHHHH | 62.85 | 26320211 | |
| 284 | Ubiquitination | AKTVSPEKLLEKAFA HHHCCHHHHHHHHHH | 62.85 | 29967540 | |
| 288 | Ubiquitination | SPEKLLEKAFAIRLF CHHHHHHHHHHHHHH | 49.09 | 19608861 | |
| 288 | Acetylation | SPEKLLEKAFAIRLF CHHHHHHHHHHHHHH | 49.09 | 19608861 | |
| 288 | Malonylation | SPEKLLEKAFAIRLF CHHHHHHHHHHHHHH | 49.09 | 26320211 | |
| 298 | Ubiquitination | AIRLFSRKEIQLLQM HHHHHCHHHHHHHHH | 58.95 | - | |
| 305 | Sulfoxidation | KEIQLLQMANEKALK HHHHHHHHHCHHHHH | 4.33 | 21406390 | |
| 312 | Acetylation | MANEKALKQKGITVK HHCHHHHHHCCCCEE | 55.62 | 19608861 | |
| 314 | Acetylation | NEKALKQKGITVKQK CHHHHHHCCCCEEEE | 51.17 | 19608861 | |
| 319 | Acetylation | KQKGITVKQKSVSLS HHCCCCEEEEEECCC | 43.27 | 25953088 | |
| 319 | Ubiquitination | KQKGITVKQKSVSLS HHCCCCEEEEEECCC | 43.27 | 27667366 | |
| 322 | Phosphorylation | GITVKQKSVSLSKRQ CCCEEEEEECCCHHH | 17.91 | 23532336 | |
| 324 | Phosphorylation | TVKQKSVSLSKRQFV CEEEEEECCCHHHHH | 33.73 | 26437602 | |
| 346 | Phosphorylation | NFRSEIVSVREMRDI HHHHHCEEHHHHHHH | 22.55 | 24719451 | |
| 421 | Acetylation | ERNKFGGKLGFFGTG HHCCCCCCCEEECCC | 45.90 | 25953088 | |
| 442 | Phosphorylation | LQPEVQRYEWVVIKH ECHHHEEEEEEEEEC | 9.32 | 27642862 | |
| 453 | Phosphorylation | VIKHPELTKPPPLMA EEECHHHCCCCCCEE | 39.58 | 28857561 | |
| 454 | Ubiquitination | IKHPELTKPPPLMAA EECHHHCCCCCCEEC | 69.06 | - | |
| 464 | Phosphorylation | PLMAAEPTAPLSHSA CCEECCCCCCCCCCC | 32.20 | 30108239 | |
| 468 | Phosphorylation | AEPTAPLSHSASSDP CCCCCCCCCCCCCCH | 17.84 | 27794612 | |
| 470 | Phosphorylation | PTAPLSHSASSDPAD CCCCCCCCCCCCHHH | 26.86 | 27794612 | |
| 472 | Phosphorylation | APLSHSASSDPADRL CCCCCCCCCCHHHHH | 37.98 | 29255136 | |
| 473 | Phosphorylation | PLSHSASSDPADRLS CCCCCCCCCHHHHHH | 47.53 | 29255136 | |
| 474 | Phosphorylation | LSHSASSDPADRLSP CCCCCCCCHHHHHHH | 39.65 | 32142685 | |
| 480 | Phosphorylation | SDPADRLSPFLAARH CCHHHHHHHHHHHHH | 17.94 | 29255136 | |
| 492 | Phosphorylation | ARHFNLPSKTESMFM HHHCCCCCCCHHHEE | 56.21 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TBC24_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TBC24_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBC24_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of TBC24_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 605021 | Familial infantile myoclonic epilepsy (FIME) | |||||
| 615338 | Epileptic encephalopathy, early infantile, 16 (EIEE16) | |||||
| 616044 | Deafness, autosomal dominant, 65 (DFNA65) | |||||
| 220500 | Deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome (DOORS) | |||||
| 614617 | Deafness, autosomal recessive, 86 (DFNB86) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-288; LYS-312; LYS-314 ANDLYS-319, AND MASS SPECTROMETRY. | |